Biotech

All Articles

Lykos will certainly talk to FDA to reexamine its own selection observing rejection of MDMA therapy for post-traumatic stress disorder

.Observing a bad revealing for Lykos Rehabs' MDMA applicant for post-traumatic stress disorder at a ...

AN 2 halves headcount, quits phase 3 trial after data dissatisfy

.AN2 Therapies is actually reviewing its service in reaction to uninspired midphase data, swearing t...

Merck pays for $700M for bispecific, spying autoimmune opening and also opportunity to test Amgen in cancer cells

.Merck &amp Co. is actually paying $700 million upfront to test Amgen in a blood cancer market. The ...

Gilead pays out J&ampJ $320M to leave licensing offer for seladelpar

.Along With Gilead Sciences almost an FDA decision for its own liver disease medicine seladelpar, th...

' All hands on deck' at Lilly as peers target obesity market

.Chief executive officer David Ricks can easily see the business establishing outdoors tents at base...

Entero laying off staff, moving out of workplace as well as stopping briefly R&ampD

.Bed Liquidators has actually turned Entero Rehabs white as a piece. The collector purchased Entero ...

Exelixis falls ADC after determining it is actually no match for Tivdak

.Exelixis is actually quiting on its cells variable (TF)- targeting antibody-drug conjugate after wr...

Relay loses interest in SHP2 inhibitor after Genentech leaves behind

.3 full weeks after Roche's Genentech system bowed out an SHP2 inhibitor contract, Relay Therapeutic...

Stoke's Dravet syndrome med released of predisposed professional grip

.Stoke Therapies' Dravet syndrome drug has actually been without a partial grip, clearing the techni...

Fierce Biotech's Gabrielle Masson provides Brutal 15 at NYSE

.Tough Biotech Partner Publisher Gabrielle Masson provided the 2024 class of Brutal 15 winners on th...